checkCrc - If set to true, the CRC will be checked for each chunk and an error will be thrown in case it's wrong (default: false). png - An object representing the ...
The study by Ma et al. provides fundamental findings and compelling evidence that Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A ...
This study provides valuable insights into the efficacy and safety of pyrotinib as an extended adjuvant therapy following trastuzumab-based treatment in patients with high-risk HER2-positive breast ...
Onvansertib in combination with trastuzumab deruxtecan (T-DXd) was well tolerated, overcame T-DXd resistance, and displayed enhanced anti-tumor activity compared to monotherapies in drug resistant HR+ ...
Image processing is manipulation of an image that has been digitised and uploaded into a computer. Software programs modify the image to make it more useful, and can for example be used to enable ...
Happy Maha Shivratri 2025 Wishes Images, Messages, Status, Photos, Quotes: Maha Shivratri, or the “Great Night of Shiva,” is a significant Hindu festival celebrated by people in India, Nepal, and ...
TL;DR: AMD is bringing in a next-gen AFMF, version 2.1, that's expected to launch with its RX 9070 GPUs, benefiting from enhanced image quality while still working with existing GPUs - it won't be ...
Photographer Tom Nickels watched the scene from a safe distance on a boat and snapped a captivating image (seen above) of the moment. Nickels’ photograph took gold in the Behavior-Mammals ...
Funda Meric-Bernstam, MD, discusses updated findings from the phase 1 TROPION-PanTumor01 study of datopotamab deruxtecan-dlnk in heavily pretreated locally advanced or metastatic urothelial cancer.
I have tested multiple AI models, particularly image models and they each have something unique to offer. AI image generation has come a long way in a few short years. The first version of ...
Crit Rev Oncol Hematol. 2020;148:102906. 8 Li, B.T. et al. Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer. N Engl J Med. 2022;386:241–51. 9 Galogre M, et al. A review of HER2 ...
A first-in-human phase 1 study of LY3866288 (LOXO-435), a potent, highly isoform-selective FGFR3 inhibitor (FGFR3i) in advanced solid tumors with FGFR3 alterations: Initial results from FORAGER-1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results